Arotinolol
Cat. No.：YN320566
| 产品名称: | Arotinolol |
| CAS No.: | 68377-92-4 |
| Chemical Name: | 5-[2-[[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropyl]thio]-4-thiazolyl]-2-thiophenecarboxamide; (±)-5-[2-[[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropyl]thio]-4-thiazolyl]-2-thiophenecarboxamide; (±)-Arotinolol; 2-(3-tert-Butylamino-2-hydroxypropylthio)-4-( |
| Synonyms: | |
| 分子量: | 371.54 |
| 分子式: | C₁₅H₂₁N₃O₂S₃ |
| SMILES: | O=C(C1=CC=C(C2=CSC(SCC(O)CNC(C)(C)C)=N2)S1)N |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Arotinolol 是一种非选择性的 α/β-肾上腺素受体 (α/β-adrenergic receptor) 阻滞剂和一种血管扩张性 β-受体阻滞剂。Arotinolol 也显示出抑制放射性配体125I-ICYP 与5HT1B-羟色胺受体能结合的能力。Arotinolol 是一种抗高血压试剂，可用于研究各种心血管疾病。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Kuroda, Y., et al.: Neurology, 38, 650 (1988)
Miyagishi, A., et al.: Arch. Pharmacodyn. Ther., 271, 249 (1984)
Wu, H., et al.: Hypertens. Res.: Off. J. Jpn. Soc. Hypertens., 24, 605 (2001)
